Michael Grunebaum
Associate Professor of Psychiatry at Columbia University Irving Medical Center; Research Psychiatrist at the New York State Psychiatric Institute
Key Impact
He is a leading ketamine and suicidality researcher whose clinical trials and meta-analytic work helped shape rapid-acting antidepressant research in psychiatry.
Background & Research
Michael F. Grunebaum, MD, is a psychiatrist and clinical researcher at Columbia University focused on mood disorders, suicidal behavior, and treatment studies. He earned his MD from Harvard Medical School and completed psychiatry training in New York, later joining Columbia/New York State Psychiatric Institute, where he has led and co-led multiple ketamine studies.
Collaboration Network
16 collaborators· click a node to visit their profile
Full network →